FILE:WAG/WAG-8K-20040112141455.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
 
 
 
Item 5: OTHER EVENTS AND REGULATION FD DISCLOSURE.
On January 12, 2004, Walgreen Co. announced that it had reached a one-year agreement with NASDAQ to dual list its stock on the NASDAQ and the New York Stock Exchange. In connection with this announcement, Walgreen Co. issued a press release, a copy of which is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c)    Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DEERFIELD, Ill., Jan. 12, 2004  Walgreen Co. (NYSE: WAG) today announced it has reached a one-year agreement with NASDAQ to dual list its stock on the NASDAQ and the New York Stock Exchange. The dual listing is expected to become effective within several weeks.
"By dual listing, we'll bring more competition to the markets and provide investors with more choice in trading venues," said Walgreens Chairman Dave Bernauer. "We believe this move is in the best interests of both our individual and institutional shareholders."
Walgreen stock has traded on the NYSE since Feb. 15, 1934. The stock will trade on the NASDAQ under the same symbol, WAG. Walgreens also will continue using the NYSE closing price as its stock price of record.
Walgreen Co. is the nation's largest drugstore chain, with fiscal 2003 sales of $32.5 billion and 4,290 stores in 44 states and Puerto Rico. The company, which plans to open 450 new stores nationwide in fiscal 2004, also operates Walgreens Health Initiatives, which provides pharmacy benefits management, mail service prescriptions and other clinical services.


